Quadrant Capital Group’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-995
Closed -$17.5K 1288
2026
Q1
$17.5K Sell
995
-29
-3% -$582 ﹤0.01% 2038
2025
Q4
$20.2K Buy
1,024
+29
+3% +$521 ﹤0.01% 1987
2025
Q3
$17.4K Buy
+995
New +$14.8K ﹤0.01% 1998
2025
Q2
Sell
-790
Closed -$14.7K 1370
2025
Q1
$14.7K Buy
790
+189
+31% +$2.82K ﹤0.01% 2129
2024
Q4
$6.76K Hold
601
﹤0.01% 2241
2024
Q3
$7.1K Hold
601
﹤0.01% 2235
2024
Q2
$4.7K Buy
601
+438
+269% +$2.86K ﹤0.01% 2309
2024
Q1
$809 Hold
163
﹤0.01% 2610
2023
Q4
$1.4K Sell
163
-389
-70% -$2.85K ﹤0.01% 2522
2023
Q3
$3.83K Buy
552
+345
+167% +$2.08K ﹤0.01% 2239
2023
Q2
$1.19K Buy
+207
New +$1.34K ﹤0.01% 2481

Other funds holding ALHC

Quadrant Capital Group's ALHC Position: Q2 2026 in Review

Quadrant Capital Group sold out of Alignment Healthcare (ALHC) in Q2 2026, closing a stake of 995 shares — an estimated $17.5K sold.

Quadrant Capital Group first reported a position in ALHC in Q2 2023 and held it in 11 quarters. The position peaked at $20.2K in Q4 2025. 324 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.

  • Quadrant Capital Group reported no remaining Alignment Healthcare position as of Q2 2026 after selling out during the quarter.
  • Quadrant Capital Group sold 995 Alignment Healthcare shares in Q2 2026, an estimated $17.5K.
  • Quadrant Capital Group first reported a position in Alignment Healthcare in Q2 2023 and held it in 11 quarters.
  • Quadrant Capital Group's Alignment Healthcare position peaked at $20.2K in Q4 2025.
  • 324 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.

Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.